Cardiovascular

Endocarditis prophylaxis: current ACC/AHA indications

Clinical Overview and When to Suspect Need for Endocarditis Prophylaxis

— Prosthetic cardiac valve (mechanical or bioprosthetic) or prosthetic material used for valve repair (annuloplasty rings, chords)

— Transcatheter-implanted prostheses (TAVR, transcatheter pulmonary valves)

— Prior infective endocarditis

— Congenital heart disease (CHD) in specific subsets:

— Unrepaired cyanotic CHD (including palliative shunts/conduits)

— Completely repaired CHD with prosthetic material, only during first 6 months post-procedure

— Repaired CHD with residual defects at or adjacent to the prosthetic site

— Cardiac transplant recipients with valvulopathy

— Patients with ventricular assist devices (per 2020 valve guideline)

— Mitral valve prolapse (even with regurgitation)

— Bicuspid aortic valve

— Acquired valvular disease (rheumatic, calcific AS, MR)

— Hypertrophic cardiomyopathy

— Isolated secundum ASD; repaired VSD/PDA/ASD beyond 6 months without residual defect

— Coronary artery stents, pacemakers, ICDs

Board pearl: The single most tested distractor is MVP with regurgitation — the answer is no prophylaxis. Memorize the 5 "highest-risk" buckets; everything else, even severe native valve disease, gets nothing.

Core principle: Infective endocarditis (IE) prophylaxis is now reserved for a narrow group of highest-risk cardiac patients undergoing specific high-risk procedures. The 2007 AHA guideline (reaffirmed 2017/2021 ACC/AHA valve guidelines) dramatically narrowed indications after evidence showed bacteremia from daily activities (chewing, brushing) likely exceeds procedural bacteremia.

Who qualifies as "highest-risk cardiac condition":

Conditions that no longer warrant prophylaxis (common board distractors):

When to suspect a board question is testing this topic: dental cleaning before a procedure, prosthetic valve patient asking about colonoscopy, child with repaired tetralogy needing tonsillectomy, or pregnant woman with mechanical valve.

Presentation Patterns and Key History

— Adult with mechanical aortic valve scheduling a routine dental cleaning

— Child with unrepaired cyanotic CHD scheduled for tooth extraction

— Patient with prior IE needing dental implant

— TAVR recipient with periodontal disease needing scaling/root planing

— Patient 4 months s/p VSD patch repair needing dental work

— Pregnant woman with bioprosthetic valve needing dental cleaning during second trimester

— Exact valve type and date of implantation (the 6-month rule for repaired CHD with prosthetic material)

— History of prior IE episodes

— Current antibiotic use (avoid same-class for prophylaxis — see chunk 7)

— Drug allergies, especially β-lactam (true IgE-mediated vs intolerance)

— Planned procedure details: is it truly a "high-risk" procedure?

— Oral hygiene status — emphasize daily oral health matters more than single-event prophylaxis

— Dental procedures involving manipulation of gingival tissue, periapical region of teeth, or perforation of oral mucosa (extractions, cleanings with bleeding, biopsies, suture removal from oral mucosa, implant placement)

— Invasive respiratory tract procedures with mucosal incision/biopsy (tonsillectomy, adenoidectomy, bronchoscopy with biopsy)

— Procedures on infected skin/musculoskeletal tissue

— Surgery to place prosthetic cardiac material

— Routine GI/GU endoscopy without active infection (colonoscopy, EGD, cystoscopy, TEE)

— Vaginal delivery, C-section, hysterectomy (no GU prophylaxis solely for IE)

— Routine bronchoscopy without biopsy

— Skin procedures on non-infected skin

— Cardiac catheterization, PCI

Key distinction: Prophylaxis is procedure-specific AND patient-specific — you need both boxes checked. A prosthetic valve patient getting a screening colonoscopy gets no antibiotic.

Clinical scenarios that trigger the prophylaxis question on Step 3 are almost always outpatient, anticipatory:

Key history elements to elicit:

Procedures that DO warrant prophylaxis (in eligible patients):

Procedures that do NOT warrant prophylaxis (frequent distractors):

Physical Exam Findings and Pre-Procedure Assessment

— Vital signs: fever, tachycardia → defer elective procedure, work up for active infection

— Skin: look for Janeway lesions, Osler nodes, splinter hemorrhages, petechiae — if present in a prosthetic valve patient, you are not giving prophylaxis, you are admitting for IE workup

— Fundoscopy: Roth spots (rare, but high-yield)

— Oral cavity: poor dentition, gingival bleeding, abscess, caries

— Cardiac: new murmur, change in prosthetic click quality, signs of heart failure

— Vascular access sites, indwelling lines, hemodialysis catheters

— Functional status (NYHA class) — declining function suggests valve dysfunction

— Signs of decompensation: JVD, S3, rales, lower-extremity edema, hepatomegaly

— Volume status before sedation/local anesthetic with vasoactive properties

— Anticoagulation review for mechanical valves — do not stop warfarin for routine dental cleaning; INR check within target before procedure

— Active oral infection → treat infection first, defer elective procedure

— Suspected IE (fever + new murmur + prosthetic valve) → blood cultures ×3, TTE → TEE, admit

— Decompensated valve disease → cardiology before any elective procedure

Step 3 management: In a prosthetic valve patient with fever and a dental abscess, do NOT simply give amoxicillin 1 hour before extraction — draw blood cultures, start empiric IE-coverage antibiotics, get TEE, consult cardiology and ID.

Although prophylaxis is a preventive decision, the pre-procedure encounter has its own exam focus aimed at detecting active infection that would change management from prophylaxis to treatment.

General assessment before clearing for procedure:

Hemodynamic and functional reassessment (especially for the valvular patient considering elective procedure):

Oral exam emphasis: Patients with the highest-risk cardiac conditions should have scheduled dental visits every 6 months with documented oral hygiene maintenance, because cumulative low-grade bacteremia from poor dentition is a larger lifetime risk than any single procedure.

When exam findings change the plan:

Diagnostic Workup — Initial Evaluation Before Procedure

— CBC — leukocytosis, anemia of chronic infection

— CRP, ESR — elevated in subacute IE

— Blood cultures × 3 from separate sites ≥1 hour apart before any antibiotic if IE is suspected (do not contaminate cultures with prophylaxis dose)

— Urinalysis — microscopic hematuria suggests embolic phenomena or immune complex GN

— ECG — baseline; new AV block in prosthetic valve patient → perivalvular abscess concern

— TTE — first-line imaging for native valves and screening

— CXR — septic pulmonary emboli (right-sided IE), pulmonary edema

Board pearl: The classic trap — a patient with prosthetic valve presents with 2 weeks of low-grade fevers and fatigue the day before dental cleaning. The correct action is not to give amoxicillin 1 hour pre-procedure; it is to obtain 3 sets of blood cultures and TEE because the question is testing recognition of subacute IE, not prophylaxis. Always ask: Is this prevention or is it missed disease?

Prophylaxis decisions rarely require lab testing, but pre-procedural assessment in high-risk cardiac patients has predictable Step 3 elements when symptoms suggest something more than routine prophylaxis is needed.

Routine pre-procedure labs for prophylaxis alone: None required solely for IE prophylaxis. The decision is clinical and structural (does the patient have a qualifying condition + qualifying procedure?).

Labs/imaging that are appropriate when concern arises:

INR for patients on warfarin: Confirm therapeutic INR within target range; dental cleanings and extractions are safe with INR up to ~3.5 — bridging is not routine and increases bleeding risk.

Renal/hepatic function: Influences antibiotic dosing in some regimens (e.g., clindamycin no longer first-line, but other agents like azithromycin still require awareness in hepatic impairment).

Pregnancy testing: Before any imaging using ionizing radiation in a woman of reproductive age.

Diagnostic Workup — Advanced Studies When IE Is Suspected

— TTE first in low-suspicion native valve cases; sensitivity ~70% for vegetations >3mm

— TEE is required in: prosthetic valves, intracardiac devices, prior IE, suspected perivalvular complication (abscess, fistula, dehiscence), persistent bacteremia

— TEE sensitivity ~95% for vegetations and >90% for abscess

— Repeat TEE in 5–7 days if initial negative and suspicion remains high

— Cardiac CT — assess perivalvular extension, pseudoaneurysms, root abscess (especially prosthetic valves where TEE shadows)

— 18F-FDG PET/CT — adds sensitivity for prosthetic valve IE ≥3 months post-implantation; now incorporated into 2023 Duke-ISCVID criteria as a major criterion

— Brain MRI — silent emboli in up to 60% of left-sided IE; influences surgical timing

— Whole-body CT — embolic survey (splenic, renal, mycotic aneurysms)

— Serologies for culture-negative IE: Coxiella burnetii (Q fever), Bartonella, Brucella, Legionella

— 16S rRNA PCR on excised valve tissue if surgery performed

— Fungal cultures, β-D-glucan in immunocompromised or prosthetic valve patients

Key distinction: A patient with prosthetic valve and negative TTE has not been ruled out for IE — proceed to TEE. This is a frequent Step 3 trap where the resident is asked the next step after a "normal" TTE in a high-pretest-probability patient.

If your "prophylaxis" patient actually has occult IE, the workup pivots to the Duke criteria framework.

Echocardiography:

Advanced imaging:

Microbiology beyond standard cultures:

Dental panoramic X-ray and ENT evaluation: Source identification — periapical abscess, sinus disease — particularly when Streptococcus viridans group is isolated.

Risk Stratification — Matching Patient to Procedure

— Prosthetic valve / prosthetic material for valve repair / TAVR / TMVR

— Prior IE

— Specific CHD subsets (unrepaired cyanotic; <6 months after repair with prosthetic material; repaired with residual defect at prosthetic site)

— Cardiac transplant with valvulopathy

— Ventricular assist device

— Dental: manipulation of gingiva, periapical region, or perforation of oral mucosa → YES

— Respiratory: mucosal incision or biopsy (T&A, bronchoscopy with biopsy) → YES

— Infected tissue: skin, MSK, drainage of abscess → YES

— GI/GU: routine endoscopy → NO (even with biopsy, unless enterococcal infection — then treat, not prophylax)

— OB/GYN: vaginal delivery, C-section, hysterectomy → NO (the 2008 update removed this; AHA/ACC consistent)

— Cardiac: PCI, EP studies, pacemaker → NO (perioperative prophylaxis for device implantation is a surgical indication using cefazolin, different framework)

— Active GU or GI infection in highest-risk patient → use antibiotics that cover enterococci as treatment, e.g., ampicillin or amoxicillin

— Soft tissue/skin infection in highest-risk patient undergoing procedure on that tissue → cover staphylococci and β-hemolytic streptococci (e.g., cephalexin, dicloxacillin; vancomycin if MRSA risk)

— Patient already on chronic suppressive antibiotics that cover oral streptococci → use a different class (e.g., clindamycin or azithromycin) for the procedure

Step 3 management: When in doubt, default to no prophylaxis. Over-prescribing fuels resistance and C. difficile, and most "borderline" scenarios on the boards are designed to test that you know the indications are now narrow.

The decision algorithm is a 2×2 gate: qualifying cardiac condition AND qualifying procedure → prophylaxis. Miss either gate → no antibiotic.

Step 1 — Is the patient in the highest-risk cardiac category?

Step 2 — Is the procedure high-risk?

Special scenarios:

Pharmacotherapy — First-Line Prophylaxis Regimens

— Amoxicillin 2 g PO in adults

— Amoxicillin 50 mg/kg PO in children (max 2 g)

— Ampicillin 2 g IM/IV (50 mg/kg in children), OR

— Cefazolin or ceftriaxone 1 g IM/IV (50 mg/kg in children)

— Cephalexin 2 g PO (50 mg/kg in children) — cross-reactivity with penicillin is <2% with modern cephalosporins

— Or cefazolin/ceftriaxone IV if NPO

— Azithromycin 500 mg PO (15 mg/kg in children), OR

— Clarithromycin 500 mg PO (15 mg/kg)

— Doxycycline 100 mg PO (2024 AHA update added doxycycline as preferred non–β-lactam option due to better activity against viridans streptococci than macrolides)

— Clindamycin is NO LONGER recommended (2021 AHA update) due to higher rates of C. difficile and serious adverse events vs. benefit

— Cefazolin or ceftriaxone IV (avoid only if anaphylaxis to penicillin)

— If even cephalosporins contraindicated → azithromycin IV or clindamycin IV (last-resort)

Board pearl: The single most updated change is clindamycin OUT, doxycycline IN for the penicillin-allergic adult. If the answer choices include clindamycin and doxycycline, pick doxycycline.

Timing: Single dose 30–60 minutes before the procedure. If forgotten, may be given up to 2 hours after the procedure.

Standard regimen — oral, able to take PO, no penicillin allergy:

Unable to take oral medication:

Penicillin/ampicillin allergy — non-anaphylactic (e.g., rash):

Penicillin allergy — anaphylaxis, angioedema, urticaria, or severe reaction:

NPO + severe β-lactam allergy:

Pediatric weight-based dosing — always cap at adult dose.

Already on antibiotic for another reason? Choose an agent from a different class to cover potential resistant flora — e.g., patient on chronic amoxicillin → give azithromycin or doxycycline.

Procedural Considerations and Perioperative Prophylaxis Distinctions

— Goal: prevent bacteremia-related endocarditis

— Single dose, oral preferred, timed 30–60 min before

— Triggered by patient (highest-risk cardiac condition) AND procedure (dental/respiratory/infected tissue)

— Goal: prevent wound infection

— Cefazolin 2 g IV within 60 min before incision (vancomycin within 120 min)

— Re-dose for long procedures or major blood loss

— Indicated by procedure, not by valve status

— Pre-procedure cefazolin (or vancomycin if MRSA-colonized) — this is SSI prophylaxis, not IE prophylaxis

— All patients receive it regardless of valve history

— Extractions, periodontal procedures with bleeding, scaling, root planing, implants, biopsies, suture removal involving mucosa → prophylax in eligible patients

— Routine fillings without gingival manipulation, fluoride treatments, orthodontic appliance adjustments, shedding of deciduous teeth, bleeding from trauma to lips/oral mucosa → no prophylaxis

— Plain bronchoscopy → no prophylaxis

— Bronchoscopy with biopsy or rigid bronchoscopy → prophylax eligible patients

— Drainage of empyema or lung abscess → prophylax + treatment

— Established enterococcal UTI requiring cystoscopy in prosthetic valve patient → ampicillin (or vancomycin if VRE/allergic) — this is treatment, scheduled around the procedure, not single-dose prophylaxis

CCS pearl: On a CCS case where the patient is a prosthetic-valve carrier going for dental extraction, you order "Amoxicillin 2 g PO, once, 1 hour before procedure" — then move clock forward. Ordering ongoing antibiotics or vancomycin is a deduction.

Step 3 frequently blurs two different antibiotic frameworks. Keep them separate:

IE prophylaxis (this topic):

Surgical site infection (SSI) prophylaxis:

Cardiac device implantation (pacemaker, ICD, CRT, VAD, TAVR):

Dental procedures requiring closer attention:

Bronchoscopy nuance:

Infected GI/GU procedures:

Special Populations — Elderly and Renal/Hepatic Impairment

— Higher prevalence of prosthetic valves, prior IE, and degenerative valve disease (which itself is not an indication)

— Polypharmacy — review for QT-prolonging meds before giving azithromycin/clarithromycin

— Risk of C. difficile with broad-spectrum agents → another reason clindamycin fell off the list

— Confirm true penicillin allergy; many older patients carry the label without confirmed reaction → consider penicillin allergy de-labeling outpatient referral

— Drug–warfarin interactions: azithromycin and clarithromycin increase INR; single doses are usually safe but check INR a few days later in frail patients

— Amoxicillin 2 g single dose: safe in CKD without adjustment for one-time use

— Ampicillin IV 2 g: safe as single dose

— Cefazolin/ceftriaxone: single 1 g dose safe

— Vancomycin (used in some β-lactam allergic surgical scenarios): weight-based 15–20 mg/kg with renal adjustment; reserved for SSI prophylaxis, not first-line IE

— Doxycycline: no renal adjustment — favorable in CKD

— Azithromycin: no renal adjustment

— Azithromycin and clarithromycin: caution in severe hepatic dysfunction (rare cholestatic hepatitis)

— Doxycycline: caution in severe hepatic disease; consider azithromycin alternative

— Ceftriaxone: biliary sludging — avoid if biliary obstruction, but single dose generally fine

— Hemodialysis is a major IE risk factor (S. aureus bacteremia), but chronic HD alone is NOT an indication for procedural IE prophylaxis

— If they have a prosthetic valve + dental procedure → standard amoxicillin 2 g PO, timing independent of dialysis schedule (single dose)

Board pearl: Don't confuse vancomycin pre-hemodialysis (treatment of MRSA bacteremia) with IE prophylaxis — the latter is a single oral dose, not an IV infusion strategy.

Elderly considerations:

Renal impairment:

Hepatic impairment:

Dialysis patients:

Special Populations — Pregnancy, Pediatrics, and Congenital Heart Disease

— Vaginal and cesarean delivery do NOT require IE prophylaxis, even in highest-risk women — a top board distractor

— Dental cleaning in a pregnant woman with prosthetic valve → amoxicillin 2 g PO (Category B, safe across all trimesters)

— Penicillin-allergic pregnant patient → azithromycin 500 mg PO (Category B); avoid doxycycline in pregnancy and lactation

— Cefazolin/ceftriaxone safe if NPO

— Anticoagulation management around dental work in pregnant mechanical valve patients requires multidisciplinary planning (cardiology, MFM)

— Weight-based: amoxicillin 50 mg/kg PO (max 2 g), 30–60 min before procedure

— Cephalexin 50 mg/kg, azithromycin 15 mg/kg, doxycycline 2.2 mg/kg (≥8 years old — avoid <8 y/o due to dental staining; use azithromycin instead)

— Shedding of primary teeth and routine orthodontic adjustments → no prophylaxis

— Tonsillectomy/adenoidectomy → prophylax eligible children

1. Unrepaired cyanotic CHD (including palliative shunts/conduits) — lifelong prophylaxis for qualifying procedures

2. Completely repaired CHD with prosthetic material/device, ONLY during first 6 months post-procedure (endothelialization period)

3. Repaired CHD with residual defect at or adjacent to prosthetic patch/device (residual shunts prevent endothelialization) — lifelong

— 4-year-old s/p tetralogy repair with patch, 3 months ago, needing dental extraction → prophylax

— Same child, 2 years post-repair, no residual defect → no prophylaxis

— Child with VSD (unrepaired, non-cyanotic) → no prophylaxis (frequent distractor — only cyanotic CHD qualifies among unrepaired lesions)

Key distinction: The 6-month rule applies only to repaired CHD with prosthetic material, not to surgical valve replacement (which is lifelong). Step 3 loves to flip this.

Pregnancy:

Pediatrics:

Congenital heart disease subsets — memorize the three CHD buckets:

Common pediatric scenarios:

Complications and Adverse Outcomes

— Even with appropriate prophylaxis, IE can still occur — efficacy data are modest because RCTs are infeasible

— Most procedure-associated IE is now thought to arise from cumulative daily bacteremia from normal activities, not single procedures — reinforcing emphasis on oral hygiene

— Presents as fevers, fatigue, embolic events, new murmur 2 weeks to 6 months post-procedure

— Workup: blood cultures × 3, TEE, Duke/ISCVID criteria

— Anaphylaxis to β-lactam: 1–5 per 10,000 doses; epinephrine-ready setting required

— C. difficile colitis: previously a major driver of removing clindamycin

— QT prolongation with azithromycin/clarithromycin — caution with concurrent QT drugs (ondansetron, methadone, fluoroquinolones)

— Rash, GI upset

— Warfarin–macrolide interaction → ↑ INR

— Antimicrobial resistance, particularly viridans streptococci macrolide resistance

— Cost and inconvenience without proven benefit in non-qualifying patients

— Allergy labeling — single doses can trigger lifelong "allergy" labels that limit future care

— Preventable IE in a true high-risk patient who didn't receive a single dose

— Particularly catastrophic in mechanical prosthetic valve patients — IE here often requires re-do surgery with high mortality

— Dental work and warfarin: hemorrhage risk balance — local hemostatic measures (tranexamic acid mouthwash) preferred over bridging

— Bacteremia post-procedure: usually transient, asymptomatic

Board pearl: A patient develops fever 3 weeks after dental work with a prosthetic valve and was never given prophylaxis — the question is rarely "should you have given it?" but rather "what is the next step now?" → blood cultures × 3 and TEE, then empiric vancomycin + ceftriaxone (or per local protocol for prosthetic valve IE) pending cultures.

Failure of prophylaxis → development of IE:

Antibiotic-related complications:

Overuse complications:

Underuse complications:

Procedural complications independent of antibiotics:

When to Escalate Care — Consults and Inpatient Triage

— New murmur in a high-risk patient

— Declining functional status with known valve disease

— Suspected prosthetic valve dysfunction

— Pre-procedural anticoagulation management complexity (mechanical valves with high-bleed-risk surgery)

— Pregnancy planning in mechanical valve patient

— Determining whether a CHD repair has residual defects requiring lifelong prophylaxis

— Suspected or confirmed IE

— Complex antibiotic allergies in a patient needing surgery on infected tissue

— Recurrent IE

— Culture-negative endocarditis

— Annual to biannual visits for all high-risk patients regardless of symptoms

— Source control before elective valve replacement (dental clearance is routine pre-op)

— Fever + prosthetic valve → admit, blood cultures, empiric coverage, TEE

— Heart failure symptoms with valve dysfunction

— Embolic phenomena (stroke, splenic infarct, mesenteric ischemia)

— Persistent bacteremia despite appropriate antibiotics

— IE with heart failure, perivalvular abscess, large mobile vegetation (>10 mm), persistent bacteremia despite 5–7 days of appropriate antibiotics, fungal IE, prosthetic valve IE with complications → early surgery, often within days

CCS pearl: In a CCS case where a prosthetic valve patient walks in with 2 weeks of fever and a new regurgitant murmur, the correct sequence is: vitals → IV access → blood cultures ×3 → CBC, CMP, ESR/CRP, UA → ECG → TTE → TEE → admit → ID and cardiology consults → empiric vancomycin + ceftriaxone (or cefepime) + gentamicin per local protocol. Don't waste a CCS clock cycle on amoxicillin "prophylaxis."

Outpatient family medicine / preventive setting handles the vast majority of IE prophylaxis decisions. Escalation is needed when:

Cardiology consult/referral indications:

Infectious disease consult indications:

Dental/oral surgery referral:

Inpatient admission indications (when prophylaxis question becomes treatment question):

ICU/cardiac surgery triage:

Key Differentials — Cardiovascular Conditions Often Confused with IE-Prophylaxis Indications

— Historically included in older guidelines; removed in 2007

— Even with murmur, thickened leaflets, or MR → no prophylaxis

— Native BAV with or without stenosis/regurgitation → no prophylaxis

— Once it receives a prosthetic AV replacement → lifelong prophylaxis

— Acquired valve disease (MS, MR, AS, AR from rheumatic origin) → no IE prophylaxis

— Note: secondary prophylaxis against streptococcal pharyngitis to prevent rheumatic fever recurrence is a separate, ongoing indication (penicillin G benzathine IM q3–4 weeks) — different concept

— Severe AS in an 80-year-old → no prophylaxis until valve is replaced

— Including obstructive HCM with SAM-mediated MR → no prophylaxis

— Isolated unrepaired ASD → no prophylaxis (not cyanotic CHD)

— Repaired ASD with device → prophylaxis only first 6 months

— Indwelling cardiac device alone → no prophylaxis for dental work

— Implantation procedure itself gets SSI prophylaxis with cefazolin (different framework)

— No IE prophylaxis ever

— Dual antiplatelet therapy continuation around dental work is the more relevant Step 3 question

Key distinction: Native valve disease, no matter how severe, does NOT qualify for IE prophylaxis. Only prosthetic material, prior IE, specific CHD, transplant valvulopathy, and VAD qualify.

Step 3 questions test whether you can correctly exclude common cardiac conditions from the prophylaxis list. Each below is a frequent distractor:

Mitral valve prolapse (MVP), with or without regurgitation:

Bicuspid aortic valve (BAV):

Rheumatic heart disease with valve involvement:

Calcific aortic stenosis (degenerative):

Hypertrophic cardiomyopathy (HCM):

Atrial septal defect (secundum):

Pacemaker, ICD, CRT:

Coronary artery stents:

Key Differentials — Non-Cardiac Mimics and Adjacent Antibiotic Decisions

— Cefazolin 2 g IV 30–60 min before incision for clean cardiac/orthopedic/vascular procedures

— Determined by procedure, not valve status

— Continued ≤24 h post-op (≤48 h for cardiac surgery in some protocols)

— ADA/AAOS 2015 guideline: routine antibiotic prophylaxis is NOT recommended for dental procedures in patients with prosthetic joints

— Individualize for immunocompromised, recent (<1 year) joint replacement, or history of prosthetic joint infection — shared decision-making

— Step 3 frequently tests that a knee replacement alone does not mandate amoxicillin before dental cleaning

— Vaccines (pneumococcal, meningococcal, Hib) and emergency antibiotic plan for febrile illness — not IE prophylaxis

— Levofloxacin prophylaxis during chemotherapy-induced neutropenia — unrelated to valve status

— Penicillin G benzathine IM q3–4 weeks for years after acute rheumatic fever to prevent recurrence

— Distinct from preventing IE on a damaged valve (which is not indicated)

— Targeted chronic antibiotic regimens unrelated to cardiac status

— Antibiotic prophylaxis not recommended

— Separate prophylactic frameworks

Board pearl: A patient with a hip replacement and mitral valve prolapse getting a dental cleaning → no antibiotics for either indication. This dual-distractor question is a Step 3 favorite. Both ADA/AAOS and AHA/ACC have moved firmly toward non-prophylaxis in marginal cases.

Step 3 also tests whether you confuse IE prophylaxis with other antibiotic-decision frameworks:

Surgical site infection (SSI) prophylaxis:

Prosthetic joint prophylaxis for dental procedures:

Splenectomy / asplenia:

Neutropenia:

Rheumatic fever secondary prophylaxis:

Recurrent UTIs, recurrent cellulitis prophylaxis:

CSF leak, basilar skull fracture:

Animal/human bites, post-exposure rabies, tetanus:

Secondary Prevention / Long-Term Plan for High-Risk Patients

— Brushing twice daily, flossing, fluoride

— Dental visits every 6 months with documented gingival health

— Aggressive treatment of caries, periodontal disease, abscesses

— Dental clearance before any planned valve surgery

— Avoid body piercings, tattoos (or insist on sterile technique)

— Prompt treatment of skin infections, especially in diabetics

— Meticulous IV catheter and hemodialysis access hygiene

— Annual influenza

— Pneumococcal (PCV15/PCV20 then PPSV23 per current ACIP)

— COVID-19 per current recommendations

— Reduce respiratory infection–related bacteremia risk

— INR target: 2.5–3.5 mechanical mitral; 2.0–3.0 mechanical aortic bileaflet

— Avoid DOACs in mechanical valves (RE-ALIGN trial)

— Bioprosthetic: warfarin × 3–6 months, then antiplatelet; or DOAC long-term per indication

— Carry a wallet card listing valve type, dates, and "highest-risk for IE — prophylaxis needed for qualifying procedures"

— Symptoms to report: unexplained fever >48 h, night sweats, fatigue, weight loss, new neurologic deficit, embolic signs

— Avoid self-prescribing antibiotics for minor illnesses

— Inform every dentist and surgeon of valve status

— Counseling, MAT (buprenorphine, methadone), harm reduction, needle exchange — IVDU is the leading driver of right-sided IE

Step 3 management: A prosthetic valve patient asking for a "dental antibiotic prescription to keep at home" — counsel that prophylaxis must be timed to a specific procedure, not self-administered, and arrange a dental appointment for proper assessment.

Endocarditis prophylaxis is one piece of a lifelong preventive strategy for the highest-risk cardiac patient. Step 3 emphasizes the longitudinal management.

Oral health — the single most important long-term measure:

Skin and mucosal health:

Vaccinations:

Anticoagulation management for mechanical valves:

Patient education — discharge/clinic counseling:

Address modifiable IV drug use:

Follow-Up, Monitoring, and Counseling

— Primary care: at least annually, more often for comorbidities

— Cardiology: every 6–12 months for prosthetic valves; sooner if symptomatic

— Echocardiogram: baseline post-op, then per valve type (bioprosthetic surveillance ~5 years post-op, then annually)

— Dental: every 6 months with documented oral hygiene

— Confirm patient still meets highest-risk criteria (especially CHD patients who may exit the 6-month window)

— Confirm procedure is on the qualifying list

— Allergy reconciliation

— Medication reconciliation (current antibiotics, anticoagulation, QT drugs)

— Document plan in chart with reasoning

— Why daily oral hygiene matters more than one-time antibiotics

— Why most procedures (colonoscopy, vaginal delivery, joint replacement) do not need IE prophylaxis

— Symptoms of IE — empower patient to seek care for unexplained fever

— Avoid IV drug use

— Vaccination plan

— Single-dose regimens rarely require active monitoring

— Check INR within 3–5 days if macrolide given to warfarin patient

— Counsel on watching for rash, diarrhea, allergic reactions

— After valve surgery hospital discharge: clear documentation to PCP and dentist

— Provide a written prophylaxis card

— Reconcile with pharmacy to avoid contraindicated antibiotic prescriptions later

— Update problem list explicitly: "Highest IE risk — requires AHA prophylaxis for qualifying procedures"

Board pearl: Ongoing dental surveillance every 6 months in highest-risk patients is the single strongest long-term recommendation — outweighing the questionable benefit of any individual procedural antibiotic dose. Counseling on oral hygiene is the more correct answer when "best long-term strategy to prevent IE" appears on a stem.

Visit cadence for the highest-risk cardiac patient:

Pre-procedure checklist (every time):

Counseling points to deliver and document:

Monitoring post-prophylaxis:

Care transitions (a Step 3 emphasis):

Ethical, Legal, and Patient Safety Considerations

— Patients should be told the evidence is observational, that single-dose prophylaxis carries small but real risks (allergic reaction, C. diff, resistance), and that benefit is presumed rather than proven by RCT

— Document the decision-making conversation, especially when patients decline prophylaxis

— Prosthetic joint + dental work

— Bicuspid aortic valve with very mild changes

— Patients with anxiety who request prophylaxis despite not meeting criteria — counsel honestly; document; avoid antibiotic overuse driven solely by patient pressure

— Each unnecessary dose contributes to community resistance and personal C. difficile risk

— Family medicine and dentistry are major outpatient prescribers — stewardship responsibility is shared

— ~90% of "penicillin-allergic" patients are not truly allergic

— Outpatient allergy referral for skin testing or oral challenge in high-risk cardiac patients improves access to first-line β-lactams over a lifetime — a patient safety win

— Discharge after valve surgery without clear prophylaxis documentation is a common safety event

— Standardized discharge templates and wallet cards reduce missed prophylaxis at downstream dental visits

— IV drug use–related IE: report nothing mandatorily for endocarditis itself, but evaluate for HIV/HCV (reportable), offer MAT, harm reduction

— In pediatric cases, ensure neglect/abuse is not contributing to delayed dental care

— Pregnant patients with mechanical valves: ensure MFM involvement and shared documentation across cardiology, OB, and dentistry

— Failure to give appropriate SSI prophylaxis is a tracked quality metric for cardiac surgery — don't confuse with IE prophylaxis

— Adverse drug reactions from inappropriate prophylaxis (e.g., anaphylaxis from antibiotics given to a non-indicated patient) carry medicolegal exposure

Step 3 management: When a patient with MVP demands amoxicillin before dental work, the correct action is patient education and documented shared decision-making, not capitulation. Stewardship and safety override patient preference when no indication exists.

Informed consent for prophylaxis:

Shared decision-making in gray zones:

Antimicrobial stewardship:

Penicillin allergy de-labeling:

Transition-of-care risk:

Mandatory reporting / public health intersections:

Liability/quality measures:

High-Yield Associations and Rapid-Fire Clinical Facts

— Prosthetic valve / prosthetic valve material

— Prior IE

— Specific CHD (unrepaired cyanotic; <6 mo post repair with prosthetic; repaired with residual defect)

— Cardiac transplant with valvulopathy

— VAD

— Dental with mucosal/gingival/periapical manipulation

— Respiratory with mucosal incision/biopsy

— Procedures on infected skin, MSK, or other tissue

— A moxicillin 2 g PO (first-line)

— A mpicillin / cefazolin / ceftriaxone 2 g IV/IM (NPO)

— C ephalexin 2 g PO (non-anaphylactic β-lactam allergy)

— A zithromycin 500 mg or D oxycycline 100 mg PO (anaphylactic β-lactam allergy)

— NO clindamycin (2021 update)

— MVP, BAV, calcific AS, HCM, rheumatic valve disease

— Pacemaker/ICD, coronary stents, prosthetic joints

— Routine GI/GU endoscopy, vaginal/cesarean delivery, hysterectomy

— Repaired CHD beyond 6 months without residual defect

Board pearl: If a question stem includes both "penicillin-allergic anaphylaxis" AND "prosthetic valve" AND "dental extraction," the answer is doxycycline 100 mg PO or azithromycin 500 mg PO, single dose, 30–60 min prior. Clindamycin in the options is a 2021-update trap.

Prophylaxis-eligible cardiac conditions — the "Big Five":

Qualifying procedures (Big Three categories):

Drug regimen quick recall:

Pediatric: 50 mg/kg amoxicillin, max 2 g. Always 30–60 min before procedure.

NOT indicated for prophylaxis (top distractors):

The 6-month window: only for repaired CHD with prosthetic material/device without residual defect.

Anticoagulation: Do NOT stop warfarin for routine dental cleanings — INR-guided, local hemostasis preferred.

TEE > TTE when prosthetic valve IE is suspected.

Daily oral hygiene > single-dose antibiotics for cumulative IE risk.

Cardiac device implantation = SSI prophylaxis (cefazolin), not IE prophylaxis.

Doxycycline is the new preferred non-β-lactam option (replacing clindamycin).

Board Question Stem Patterns

— Stem: 45-year-old with MVP and mild MR scheduled for dental cleaning.

— Answer: No prophylaxis indicated. Distractors: amoxicillin 2 g, clindamycin, cephalexin. Pick "no antibiotic."

— Stem: 68-year-old with mechanical aortic valve scheduled for screening colonoscopy.

— Answer: No prophylaxis. Routine GI endoscopy does not warrant it.

— Stem: 55-year-old with bioprosthetic mitral valve and good dentition needs a tooth extraction.

— Answer: Amoxicillin 2 g PO 30–60 min before procedure.

— Stem: Above patient reports anaphylaxis to penicillin.

— Answer: Doxycycline 100 mg PO or azithromycin 500 mg PO (NOT clindamycin if both options offered).

— Stem: 5-year-old, 4 months post Fontan with prosthetic conduit, no residual shunt, needs dental extraction.

— Answer: Amoxicillin 50 mg/kg PO (still within 6-month window).

— Same child at 9 months post-op, no residual → no prophylaxis.

— Stem: Pregnant woman with prosthetic mitral valve having planned vaginal delivery.

— Answer: No IE prophylaxis indicated.

— Stem: Hip replacement + MVP, needs dental cleaning.

— Answer: No antibiotic prophylaxis.

— Stem: Prosthetic valve patient with 3 weeks of low-grade fever before dental cleaning.

— Answer: Blood cultures × 3 and TEE, not amoxicillin 1 hour prior.

— Stem: Pacemaker about to be implanted.

— Answer: Cefazolin IV as SSI prophylaxis (not classic IE prophylaxis).

— Stem: Highest-risk patient on chronic amoxicillin for another indication; needs dental work.

— Answer: Use a different class — azithromycin or doxycycline.

Key distinction: Always do the two-gate check mentally before picking any antibiotic answer choice.

Pattern 1 — The "removed indication":

Pattern 2 — The "qualifying patient, non-qualifying procedure":

Pattern 3 — The "qualifying patient AND qualifying procedure":

Pattern 4 — Penicillin allergy:

Pattern 5 — Pediatric CHD with the 6-month rule:

Pattern 6 — Obstetric distractor:

Pattern 7 — Prosthetic joint + native heart:

Pattern 8 — Occult IE masquerading as prophylaxis question:

Pattern 9 — Device implantation:

Pattern 10 — Already on antibiotics:

One-Line Recap

Endocarditis prophylaxis is indicated only when a highest-risk cardiac patient (prosthetic valve/material, prior IE, specific CHD, cardiac transplant with valvulopathy, or VAD) undergoes a qualifying procedure (dental with gingival/mucosal manipulation, respiratory with mucosal biopsy, or procedure on infected tissue) — given as a single dose of amoxicillin 2 g PO 30–60 min before, with doxycycline or azithromycin (NOT clindamycin) replacing it in penicillin-anaphylactic patients.

Two-gate rule: Qualifying patient AND qualifying procedure — both required, or no antibiotic.

Top 5 distractors that get NO prophylaxis: MVP, bicuspid aortic valve, calcific/rheumatic native valve disease, HCM, and prosthetic joints — plus routine GI/GU endoscopy and vaginal/cesarean delivery in any patient.

Drug update (2021–2024 AHA): Amoxicillin 2 g PO first-line; cephalexin for non-anaphylactic β-lactam allergy; doxycycline 100 mg or azithromycin 500 mg for anaphylactic allergy; clindamycin is no longer recommended due to C. difficile risk.

Long-term emphasis: Twice-daily oral hygiene, dental visits every 6 months, vaccination, and avoidance of IV drug use prevent more IE than any single antibiotic dose — counsel the patient at every visit, document the highest-risk status on the problem list, and issue a wallet card to bridge transitions of care across dentistry, surgery, cardiology, and primary care.